Effects of nicotine in the dopaminergic system of mice lacking the alpha4 subunit of neuronal nicotinic acetylcholine receptors

The mesostriatal dopaminergic system influences locomotor activity and the reinforcing properties of many drugs of abuse including nicotine. Here we investigate the role of the α4 nicotinic acetylcholine receptor (nAChR) subunit in mediating the effects of nicotine in the mesolimbic dopamine system in mice lacking the α4 subunit. We show that there are two distinct populations of receptors in the substantia nigra and striatum by using autoradiographic labelling with 125I α‐conotoxin MII. These receptors are comprised of the α4, β2 and α6 nAChR subunits and non‐α4, β2, and α6 nAChR subunits. Non‐α4 subunit‐containing nAChRs are located on dopaminergic neurons, are functional and respond to nicotine as demonstrated by patch clamp recordings. In vivo microdialysis performed in awake, freely moving mice reveal that mutant mice have basal striatal dopamine levels which are twice as high as those observed in wild‐type mice. Despite the fact that both wild‐type and α4 null mutant mice show a similar increase in dopamine release in response to intrastriatal KCl perfusion, a nicotine‐elicited increase in dopamine levels is not observed in mutant mice. Locomotor activity experiments show that there is no difference between wild‐type and mutant mice in basal activity in both habituated and non‐habituated environments. Interestingly, mutant mice sustain an increase in cocaine‐elicited locomotor activity longer than wild‐type mice. In addition, mutant mice recover from depressant locomotor activity in response to nicotine at a faster rate. Our results indicate that α4‐containing nAChRs exert a tonic control on striatal basal dopamine release, which is mediated by a heterogeneous population of nAChRs.

[1]  Alain M. Gardier,et al.  Regional differences in the effect of the combined treatment of WAY 100635 and fluoxetine: an in vivo microdialysis study , 1996, Naunyn-Schmiedeberg's Archives of Pharmacology.

[2]  A. C. Collins,et al.  125I-alpha-conotoxin MII identifies a novel nicotinic acetylcholine receptor population in mouse brain. , 2000, Molecular pharmacology.

[3]  D. Colquhoun,et al.  Recombinant nicotinic receptors, expressed in Xenopus oocytes, do not resemble native rat sympathetic ganglion receptors in single‐channel behaviour. , 1997, The Journal of physiology.

[4]  D. Yoshikami,et al.  A New -Conotoxin Which Targets 32 Nicotinic Acetylcholine Receptors (*) , 1996, The Journal of Biological Chemistry.

[5]  H. Andrews,et al.  Diagnostic criteria for essential tremor: a population perspective. , 1998, Archives of neurology.

[6]  G. Chiara,et al.  Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs , 1996, Nature.

[7]  H. Mansvelder,et al.  Long-Term Potentiation of Excitatory Inputs to Brain Reward Areas by Nicotine , 2000, Neuron.

[8]  A. Karlin,et al.  Functional contributions of α5 subunit to neuronal acetylcholine receptor channels , 1996, Nature.

[9]  P. Clarke,et al.  Nicotinic binding in rat brain: autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[10]  S. Ikemoto,et al.  GABAA Receptor Blockade in the Anterior Ventral Tegmental Area Increases Extracellular Levels of Dopamine in the Nucleus Accumbens of Rats , 1997, Journal of neurochemistry.

[11]  K. Franklin,et al.  The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine , 2005, Psychopharmacology.

[12]  D. Yoshikami,et al.  A new alpha-conotoxin which targets alpha3beta2 nicotinic acetylcholine receptors. , 1996, The Journal of biological chemistry.

[13]  J. Rose,et al.  Nicotine self-administration in animals and humans: similarities and differences , 1997, Psychopharmacology.

[14]  B. K. Hartman,et al.  Distribution of pontomesencephalic cholinergic neurons projecting to substantia nigra differs significantly from those projecting to ventral tegmental area , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[15]  I. Scheffer,et al.  Phenotypic Characterization of an α4 Neuronal Nicotinic Acetylcholine Receptor Subunit Knock-Out Mouse , 2000, The Journal of Neuroscience.

[16]  J. Changeux,et al.  Distribution and Pharmacology of α6-Containing Nicotinic Acetylcholine Receptors Analyzed with Mutant Mice , 2002, The Journal of Neuroscience.

[17]  C. Blaha,et al.  Modulation of dopamine efflux in the nucleus accumbens after cholinergic stimulation of the ventral tegmental area in intact, pedunculopontine tegmental nucleus-lesioned, and laterodorsal tegmental nucleus-lesioned rats , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[18]  M. Jarvik,et al.  Acute and chronic tolerance to nicotine measured by activity in rats , 1973, Psychopharmacologia.

[19]  J. Changeux,et al.  Reduced antinociception in mice lacking neuronal nicotinic receptor subunits , 1999, Nature.

[20]  B. Wainer,et al.  Ascending projections from the pedunculopontine tegmental nucleus and the adjacent mesopontine tegmentum in the rat , 1988, The Journal of comparative neurology.

[21]  Michele Zoli,et al.  Molecular and Physiological Diversity of Nicotinic Acetylcholine Receptors in the Midbrain Dopaminergic Nuclei , 2001, The Journal of Neuroscience.

[22]  G. Koob Drugs of abuse: anatomy, pharmacology and function of reward pathways. , 1992, Trends in pharmacological sciences.

[23]  E. Albuquerque,et al.  Diversity of nicotinic acetylcholine receptors in rat hippocampal neurons. I. Pharmacological and functional evidence for distinct structural subtypes. , 1993, The Journal of pharmacology and experimental therapeutics.

[24]  S. Iversen,et al.  Selective 6OHDA-induced destruction of mesolimbic dopamine neurons: abolition of psychostimulant-induced locomotor activity in rats. , 1976, European journal of pharmacology.

[25]  A. C. Collins,et al.  Involvement of the alpha3 subunit in central nicotinic binding populations. , 2002, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[26]  V. Gerzanich,et al.  "Orphan" alpha6 nicotinic AChR subunit can form a functional heteromeric acetylcholine receptor. , 1997, Molecular pharmacology.

[27]  M. Jarvik,et al.  Nicotine tolerance in rats; role of dose and dose interval , 1974, Psychopharmacologia.

[28]  J. Changeux,et al.  Identification of Four Classes of Brain Nicotinic Receptors Using β2 Mutant Mice , 1998, The Journal of Neuroscience.

[29]  S. Iversen,et al.  Selective 60HDA-induced destruction of mesolimbic dopamine neurons: Abolition of psychostimulant-induced locomotor activity in rats , 1976 .

[30]  C. Luetje,et al.  Neuronal Nicotinic Receptor β2 and β4 Subunits Confer Large Differences in Agonist Binding Affinity , 1998 .

[31]  J. Changeux,et al.  Neuronal Nicotinic Receptor a6 Subunit mRNA is Selectively Concentrated in Catecholaminergic Nuclei of the Rat Brain , 1996, The European journal of neuroscience.

[32]  S. Deadwyler,et al.  Firing Rate of Nucleus Accumbens Neurons Is Dopamine-Dependent and Reflects the Timing of Cocaine-Seeking Behavior in Rats on a Progressive Ratio Schedule of Reinforcement , 2000, The Journal of Neuroscience.

[33]  A. Levey,et al.  Cholinergic vs. noncholinergic efferents from the mesopontine tegmentum to the extrapyramidal motor system nuclei , 1988, The Journal of comparative neurology.

[34]  J. Changeux,et al.  Ultrastructural localization of the alpha4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra. , 1999, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[35]  D. Colquhoun,et al.  A Reporter Mutation Approach Shows Incorporation of the “Orphan” Subunit β3 into a Functional Nicotinic Receptor* , 1998, The Journal of Biological Chemistry.

[36]  John T. Williams,et al.  Nicotine activates and desensitizes midbrain dopamine neurons , 1997, Nature.

[37]  C. Luetje,et al.  Neuronal nicotinic receptor beta2 and beta4 subunits confer large differences in agonist binding affinity. , 1998, Molecular pharmacology.

[38]  J. Lindstrom,et al.  Single channel properties of human α3 AChRs: impact of β2, β4 and α5 subunits , 1999 .

[39]  C. Blaha,et al.  Laterodorsal tegmental stimulation elicits dopamine efflux in the rat nucleus accumbens by activation of acetylcholine and glutamate receptors in the ventral tegmental area , 2000, The European journal of neuroscience.

[40]  W. Corrigall,et al.  Self-administered nicotine activates the mesolimbic dopamine system through the ventral tegmental area , 1994, Brain Research.

[41]  J. Lindstrom,et al.  Human α6 AChR subtypes: subunit composition, assembly, and pharmacological responses , 2000, Neuropharmacology.

[42]  A. C. Collins,et al.  Differential agonist inhibition identifies multiple epibatidine binding sites in mouse brain. , 1998, The Journal of pharmacology and experimental therapeutics.

[43]  A. C. Collins,et al.  Characterization of Nicotinic Receptor‐Mediated [3H]Dopamine Release from Synaptosomes Prepared from Mouse Striatum , 1992, Journal of neurochemistry.

[44]  A. C. Collins,et al.  Involvement of the α3 Subunit in Central Nicotinic Binding Populations , 2002, The Journal of Neuroscience.

[45]  J. Changeux,et al.  Acetylcholine receptors containing the β2 subunit are involved in the reinforcing properties of nicotine , 1998, Nature.

[46]  A. Levey,et al.  The origins of cholinergic and other subcortical afferents to the thalamus in the rat , 1987, The Journal of comparative neurology.

[47]  W. Corrigall,et al.  Selective dopamine antagonists reduce nicotine self-administration , 2005, Psychopharmacology.

[48]  J. Bolam,et al.  Cholinergic, GABAergic, and glutamate-enriched inputs from the mesopontine tegmentum to the subthalamic nucleus in the rat , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[49]  H. Fibiger,et al.  Evidence that mesolimbic dopaminergic activation underlies the locomotor stimulant action of nicotine in rats. , 1988, The Journal of pharmacology and experimental therapeutics.

[50]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .